SNYNF News Today: Stay Updated with the Latest Sanofi News in Real Time
Find SNYNF news now at Meyka AI. Stay informed with the latest{" "} Sanofi stocks updates, including price news, market analysis, and expert insights.
GV.PA Stock Surges 5.88% on Heavy Trading Volume Today
Genomic Vision SA (GV.PA) gains 5.88% with 38.5M shares traded on EURONEXT. Healthcare diagnostics stock shows intraday strength.
ALINT.PA stock surges 45% on high volume trading May 8
ALINT.PA stock jumps 45% with 86,552 shares traded. IntegraGen SA genomics services drive volume surge on EURONEXT.
BNTX BioNTech SE Earnings: Beat EPS, Missed Revenue
BioNTech beat EPS by 3.72% but missed revenue by 34.22%. Q1 2026 earnings show mixed results for the biotech company.
22UA.F BioNTech SE Earnings Beat EPS, Misses Revenue
BioNTech SE (22UA.F) beat EPS estimates by 11.24% but missed revenue by 34.22% in Q1 2026 earnings.
SGMO Stock Surges 31.5% as Sangamo Therapeutics Nears May 11 Earnings
SGMO stock jumped 31.5% to $0.1776 on May 5, 2026. Sangamo Therapeutics reports Q1 earnings Monday with analyst expectations of $0.0050 EPS.
RVMD Earnings Preview: Revolution Medicines Reports May 6
Revolution Medicines (RVMD) reports Q1 earnings May 6. Analysts expect -$1.83 EPS and $2.42M revenue. Stock up 6% ahead of release.
ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates
Alnylam Pharmaceuticals (ALNY) crushed Q1 2026 earnings with EPS of $1.51 vs $0.90 estimate, up 68.72%. Revenue hit $1.17B, beating by 4.63%.
SAP.DE Stock Slides 0.26% on May 1 as AI Demand Shifts
SAP.DE trades at €145.50 on XETRA, down 0.26% intraday. Enterprise software leader faces headwinds despite strong fundamentals and B+ grade.
BCYC: Jefferies Maintains Buy Rating, April 2026
Jefferies maintains Buy rating on Bicycle Therapeutics (BCYC) with price target lowered to $12 from $13.